| License: Creative Commons Attribution 4.0 Early View (476kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-782907
- DOI to cite this document:
- 10.5283/epub.78290
This publication is part of the DEAL contract with Wiley.
Abstract
Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available. Inflammatory cytokines including interleukin-6 (IL6), interleukin-8 (IL8), and tumor necrosis factor-alpha (TNF-α) may reflect systemic immune ...

Owner only: item control page

Download Statistics